Josep M. Roncero

Randomized Phase III Study of Alisertib or Investigator’s Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma

Owen A. O’Connor, Muhıt Özcan, Eric D. Jacobsen et al. · Journal of Clinical Oncology · 2019 · 150 citations · Full text

Medicine, Oncology, Pharmacology +17

Mannan-binding lectin pathway deficiencies and invasive fungal infections following allogeneic stem cell transplantation

Miquel Granell, Álvaro Urbano-Ispizúa, B. Suárez et al. · Experimental Hematology · 2006 · 93 citations

Life Sciences, Immunology, Microbiology +16

Chronic lymphocytic leukaemia with 17p deletion: a retrospective analysis of prognostic factors and therapy results

Julio Delgado, Blanca Espinet, Ana Carla Oliveira et al. · British Journal of Haematology · 2012 · 46 citations · Full text

Medicine, Oncology, Pathology +13

Kinetics of the CTLA-4 isoforms expression after T-lymphocyte activation and role of the promoter polymorphisms on CTLA-4 gene transcription

Arianne Pérez-García, Gemma Osca‐Gelis, Anna Bosch-Vizcaya et al. · Human Immunology · 2013 · 28 citations

Life Sciences, Immunology, Molecular Biology +16

Donor CTLA-4 Genotype Influences Clinical Outcome after T Cell-Depleted Allogeneic Hematopoietic Stem Cell Transplantation from HLA-Identical Sibling Donors

Anna Bosch-Vizcaya, Arianne Pérez-García, Salut Brunet et al. · Biology of Blood and Marrow Transplantation · 2011 · 20 citations · Full text

Life Sciences, Hematology, Immunology +16